Concomitant use not recommended:Irreversible MAOIs (iproniazide): due to risk of cardiovascular collapse or paroxysmal hypertension, hyperthermia, convulsions, death.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education